Further studies on the mechanism of antipsychotic action: Potentiation by α-methyltyrosine of thioridazine effects in chronic schizophrenics

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of neural transmission

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/BF01244665PMID 4146641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of phenothiazines byα-methyltyrosine in treatment of chronic schizophrenia

  2005cited by this paper
• α-Methyl-p-tyrosine (AMT) in schizophrenia

  2004cited by this paper
• Serum levels of thioridazine in psychiatric patients and healthy volunteers

  1973cited by this paper
• 5-Hydroxyindolacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis

  1972cited by this paper
• Behavioral effects of haloperidol after tyrosine hydroxylase inhibition.

  1971cited by this paper
• Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug

  1969cited by this paper
• Alpha-methyl-p-tyrosine (AMT) in schizophrenia.

  1967cited by this paper
• Catecholamine-drug interactions in man.

  1966cited by this paper
• E. CATECHOLAMINE-DRUG INTERACTIONS IN MAN

  1966cited by this paper
• A simple and reliable subclassification of chronic schizophrenia.

  1961cited by this paper
• THE MEASUREMENT OF BEHAVIOUR IN CHRONIC SCHIZOPHRENIA

  1960cited by this paper

• Development of early diagnosis of Parkinson's disease on animal models based on the intranasal administration of α-methyl-p-tyrosine methyl ester in a gel system.

  2022cites this paper
• Medication-induced Psychotic Disorder. A Review of Selected Drugs Side Effects.

  2022cites this paper
• Theoretical studies on photo-induced electron transfer process on [Thioridazine].C60 nano-complex; a first principle DFT and TD-DFT

  2020cites this paper
• Glutamate and dopamine in schizophrenia: An update for the 21st century

  2015cites this paper
• 22q11 Deletion syndrome and neurotransmitter systems in unchallenged and challenged conditions

  2010cites this paper
• UvA-DARE ( Digital Academic Repository ) 22 q 11 Deletion syndrome and neurotransmitter systems in unchallenged and challenged conditions

  2010cites this paper
• Potentiation by alpha-methyltyrosine of the suppression of food-reinforced lever-pressing behaviour induced by antipsychotic drugs.

  2009cites this paper
• Potentiation by lithium of the haloperidol-induced behavioural suppression

  2005cites this paper
• Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function

  2005cites this paper
• Antipsychotic treatment withα-methyltyrosine in combination with thioridazine: Prolactin response and interaction with dopaminergic precursor pools

  2005cites this paper
• Chapter 21 – Extraversion and the Dopamine Hypothesis

  2004cites this paper
• RMI-81,582, a novel antipsychotic drug

  2004cites this paper
• NMDA Receptor Activity and the Transmission of Sensory Input into Motor Output in Introverts and Extraverts

  2003cites this paper
• Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?

  1997cites this paper
• On dopaminergic modulation of temporal information processing.

  1993cites this paper
• Pharmacologic properties of the internal clock underlying time perception in humans.

  1992cites this paper
• Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine.

  1990cites this paper
• Approaches for finding new types of antipsychotic compounds

  1989cites this paper
• Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity.

  1986cites this paper
• Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.

  1984cites this paper
• Clonidine‐induced growth hormone secretion in chronic schizophrenia

  1983cites this paper
• [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].

  1982cites this paper
• The DSM‐III Diagnosis of Schizophrenic‐Like Illness and the Clinical: Pharmacology of Psychosis

  1982cites this paper
• The dopamine hypothesis: an overview of studies with schizophrenic patients.

  1982cites this paper
• α-Methyl-p-Tyrosine: A Review of its Pharmacology and Clinical Use

  1981cites this paper
• alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.

  1981cites this paper
• Effects of thioridazine on apomorphine-elicited stereotypic behavior and motor activity.

  1980cites this paper
• Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes.

  1980cites this paper
• Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia.

  1980cites this paper
• Neuroleptic‐potentiating effect of α‐methyl‐p‐tyrosine compared with haloperidol and placebo in a double‐blind cross‐over trial

  1979cites this paper
• Tardive dyskinesia.

  1979cites this paper
• Treatment of schizophrenia.

  1979cites this paper
• Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.

  1979cites this paper
• Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.

  1979cites this paper
• Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.

  1978cites this paper
• Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence.

  1977cites this paper
• Alcoholism and schizophrenia: diagnostic and therapeutic considerations.

  1977cites this paper
• The Significance of Dopamine for the Mode of Action of Neuroleptics and the Pathogenesis of Schizophrenia

  1977cites this paper
• Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine.

  1977cites this paper
• Haloperidol attenuation of morphine abstinence: synergistic effect of acute lithium administration

  1977cites this paper
• Methodological issues in psychopharmacological research.

  1977cites this paper
• Inhibition of tyrosine hydroxylase but not dopamine‐β‐hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics

  1976cites this paper
• Normalization by antipsychotic drugs of biochemically induced abnormal behavior in rats

  1976cites this paper
• Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.

  1976cites this paper
• The dopamine hypothesis of schizophrenia: a review.

  1976cites this paper
• Synergistic potentiation of halopoderidol‐induced catalepsy by γ‐ butyrolactone

  1976cites this paper
• [Schizophrenia and catecholamines].

  1975cites this paper
• On a prime role for newly synthesized dopamine in striatal function.

  1975cites this paper
• Antipsychotic drugs and catecholamine synapses.

  1974cites this paper
• Editorial: Animal models for evaluating psychotropic drugs.

  1974cites this paper